(Q45722521)
Statements
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type (English)
Sing-fai Leung
Anthony T C Chan
Lisa Y S Chan
Philip J Johnson
Y M Dennis Lo